ABBV Dividend History Chart
AbbVie (ABBV) Dividend Payments
| Ex-Dividend Date | Record Date | Payment Date | Dividend | Frequency |
|---|---|---|---|---|
| Jul 15, 2026 | Jul 15, 2026 | Aug 14, 2026 | $1.73 | Quarterly |
| Apr 15, 2026 | Apr 15, 2026 | May 15, 2026 | $1.73 | Quarterly |
| Jan 16, 2026 | Jan 16, 2026 | Feb 17, 2026 | $1.73 | Quarterly |
| Oct 15, 2025 | Oct 15, 2025 | Nov 14, 2025 | $1.64 | Quarterly |
| Jul 15, 2025 | Jul 15, 2025 | Aug 15, 2025 | $1.64 | Quarterly |
| Apr 15, 2025 | Apr 15, 2025 | May 15, 2025 | $1.64 | Quarterly |
| Jan 15, 2025 | Jan 15, 2025 | Feb 14, 2025 | $1.64 | Quarterly |
| Oct 15, 2024 | Oct 15, 2024 | Nov 15, 2024 | $1.55 | Quarterly |
| Jul 15, 2024 | Jul 15, 2024 | Aug 15, 2024 | $1.55 | Quarterly |
| Apr 12, 2024 | Apr 15, 2024 | May 15, 2024 | $1.55 | Quarterly |
| Jan 12, 2024 | Jan 16, 2024 | Feb 15, 2024 | $1.55 | Quarterly |
| Oct 12, 2023 | Oct 13, 2023 | Nov 15, 2023 | $1.48 | Quarterly |
| Jul 13, 2023 | Jul 14, 2023 | Aug 15, 2023 | $1.48 | Quarterly |
| Apr 13, 2023 | Apr 14, 2023 | May 15, 2023 | $1.48 | Quarterly |
| Jan 12, 2023 | Jan 13, 2023 | Feb 15, 2023 | $1.48 | Quarterly |
| Oct 13, 2022 | Oct 14, 2022 | Nov 15, 2022 | $1.41 | Quarterly |
| Jul 14, 2022 | Jul 15, 2022 | Aug 15, 2022 | $1.41 | Quarterly |
| Apr 13, 2022 | Apr 15, 2022 | May 16, 2022 | $1.41 | Quarterly |
| Jan 13, 2022 | Jan 14, 2022 | Feb 15, 2022 | $1.41 | Quarterly |
| Oct 14, 2021 | Oct 15, 2021 | Nov 15, 2021 | $1.3 | Quarterly |
| Jul 14, 2021 | Jul 15, 2021 | Aug 16, 2021 | $1.3 | Quarterly |
| Apr 14, 2021 | Apr 15, 2021 | May 14, 2021 | $1.3 | Quarterly |
| Jan 14, 2021 | Jan 15, 2021 | Feb 16, 2021 | $1.3 | Quarterly |
| Oct 14, 2020 | Oct 15, 2020 | Nov 16, 2020 | $1.18 | Quarterly |
| Jul 14, 2020 | Jul 15, 2020 | Aug 14, 2020 | $1.18 | Quarterly |
| Apr 14, 2020 | Apr 15, 2020 | May 15, 2020 | $1.18 | Quarterly |
| Jan 14, 2020 | Jan 15, 2020 | Feb 14, 2020 | $1.18 | Quarterly |
| Oct 11, 2019 | Oct 15, 2019 | Nov 15, 2019 | $1.07 | Quarterly |
| Jul 12, 2019 | Jul 15, 2019 | Aug 15, 2019 | $1.07 | Quarterly |
| Apr 12, 2019 | Apr 15, 2019 | May 15, 2019 | $1.07 | Quarterly |
| Jan 14, 2019 | Jan 15, 2019 | Feb 15, 2019 | $1.07 | Quarterly |
| Oct 12, 2018 | Oct 15, 2018 | Nov 15, 2018 | $0.96 | Quarterly |
| Jul 12, 2018 | Jul 13, 2018 | Aug 15, 2018 | $0.96 | Quarterly |
| Apr 12, 2018 | Apr 13, 2018 | May 15, 2018 | $0.96 | Quarterly |
| Jan 11, 2018 | Jan 12, 2018 | Feb 15, 2018 | $0.71 | Quarterly |
| Oct 12, 2017 | Oct 13, 2017 | Nov 15, 2017 | $0.64 | Quarterly |
| Jul 12, 2017 | Jul 11, 2017 | Aug 15, 2017 | $0.64 | Quarterly |
| Apr 11, 2017 | Apr 13, 2017 | May 15, 2017 | $0.64 | Quarterly |
| Jan 11, 2017 | Jan 13, 2017 | Feb 15, 2017 | $0.64 | Quarterly |
| Oct 12, 2016 | Oct 14, 2016 | Nov 15, 2016 | $0.57 | Quarterly |
| Jul 13, 2016 | Jul 15, 2016 | Aug 15, 2016 | $0.57 | Quarterly |
| Apr 13, 2016 | Apr 15, 2016 | May 16, 2016 | $0.57 | Quarterly |
| Jan 13, 2016 | Jan 15, 2016 | Feb 16, 2016 | $0.57 | Quarterly |
| Oct 13, 2015 | Oct 15, 2015 | Nov 16, 2015 | $0.51 | Quarterly |
| Jul 13, 2015 | Jul 15, 2015 | Aug 14, 2015 | $0.51 | Quarterly |
| Apr 13, 2015 | Apr 15, 2015 | May 15, 2015 | $0.51 | Quarterly |
| Jan 13, 2015 | Jan 15, 2015 | Feb 13, 2015 | $0.49 | Quarterly |
| Oct 10, 2014 | Oct 15, 2014 | Nov 17, 2014 | $0.42 | Quarterly |
| Jul 11, 2014 | Jul 15, 2014 | Aug 15, 2014 | $0.42 | Quarterly |
| Apr 11, 2014 | Apr 15, 2014 | May 15, 2014 | $0.42 | Quarterly |
| Jan 13, 2014 | Jan 15, 2014 | Feb 14, 2014 | $0.4 | Quarterly |
| Oct 10, 2013 | Oct 15, 2013 | Nov 15, 2013 | $0.4 | Quarterly |
| Jul 11, 2013 | Jul 15, 2013 | Aug 15, 2013 | $0.4 | Quarterly |
| Apr 11, 2013 | Apr 15, 2013 | May 15, 2013 | $0.4 | Quarterly |
| Jan 11, 2013 | Jan 15, 2013 | Feb 15, 2013 | $0.4 | Quarterly |
ABBV Dividend Statistics
Summary
AbbVie (ABBV) has maintained a consistent dividend policy, increasing its annual dividend for 12 consecutive years. The current dividend yield is 2.47%, reflecting a stable income profile for long-term dividend investors.
ABBV vs Top Dividend Stocks
| Company | Dividend Yield | Annual Dividend | Ex-Date |
|---|---|---|---|
| UnitedHealth Group | 2.39% | $9.06 | Sep 13, 2026 |
| Johnson & Johnson | 2.02% | $5.28 | Aug 24, 2026 |
| Merck & Company, Inc. | 2.34% | $3.4 | Sep 14, 2026 |
| Amgen Inc. | 2.4% | $9.94 | Aug 20, 2026 |
| Regeneron Pharmaceuticals, Inc. | 0.5% | $3.7 | Aug 17, 2026 |
| Eli Lilly and Company | 0.57% | $6.69 | Aug 13, 2026 |
| Pfizer Inc. | 6.08% | $1.72 | Jul 23, 2026 |
| Novo Nordisk A/S | 4.65% | $1.796 | Aug 16, 2026 |
| Stryker Corporation | 1.27% | $3.52 | Sep 29, 2026 |
| Novartis | 3.3% | $4.7403 | Mar 10, 2026 |
Methodology
We calculate dividend metrics using dividend payment records, historical stock prices, and company financial data obtained from trusted market data providers, including Twelve Data, Financial Modeling Prep (FMP), and Polygon.io. Historical dividend data is available from 2004 onward, subject to company listing history and data availability
Want to invest in stocks?
You can get started with the brokers below.
These platforms allow you to buy and hold shares directly.
👉 Compare brokers and get started today.
AbbVie (ABBV) Dividend FAQs
-
Does AbbVie (ABBV) pay dividends?
Yes, AbbVie (ABBV) currently pays dividends. The annual dividend (TTM) is $6.83 per share, with a current dividend yield of 2.47%.
-
What is AbbVie (ABBV)'s current dividend yield?
AbbVie (ABBV)'s current dividend yield is 2.47%, based on the latest annual dividend (TTM) and current share price.
-
When is AbbVie (ABBV)'s ex-dividend date?
No upcoming ex-dividend date has been announced.
-
What is AbbVie (ABBV)'s dividend payment frequency?
AbbVie (ABBV) pays dividends quarterly.
-
Has AbbVie (ABBV) increased its dividend over time?
Yes. AbbVie (ABBV) has increased its annual dividend for 12 consecutive years.
Latest ABBV News
Why are AbbVie shares down 2% today?
Epcoritamab plus R-CHOP Phase 3 results: Can AbbVie stock break $279.47 resistance?
AbbVie stock weekly forecast: Holds gains as buyers stay in control
AbbVie shares weekly forecast: recovery holds but faces a stretched setup
AbbVie stock edges lower after European Commission approval for pJIA treatment
Disclaimer
All information on the pages containing forecasts, video forecasts, and other analytical materials is published ‘as is’ and for informational purposes only. The information is not intended for trading or advice of financial, investment, tax, legal, accounting or any kind of nature. Before starting to trade, please contact your broker or a financial advisor to check the quotes, evaluate forecasts or the opinion of the author of the article. Our company is not an investment consultant, financial advisor or a broker for transactions involving securities. No information shall be viewed as investment advice, recommendation or offer of our company to buy, hold or sell securities or financial products. Our company does not provide guarantees and does not express opinions about appropriateness or suitability of investments.
No information shall be regarded as investment advice (general or individual). Financial products or transactions mentioned in such information may not be suitable for your investment portfolio and may not meet your investment targets and expectations. You are solely responsible for any decision regarding financial products or transactions and you shall independently determine whether they are suitable for you, taking into account your interests, investment targets, investment horizon and tolerable risk level. Our company shall not bear any responsibility for the losses caused by financial transactions or investments in financial products mentioned on our website. We do not recommend making investment decisions guided solely by this information.
The information on our website is provided by stock exchanges, brokers and other content providers, and, in some cases, may arrive with a delay. Our company does not verify such information and shall waive any liability related to it.
Our company and our information and content providers, financial exchanges, brokers and also all affiliated companies and business partners: a) expressly waive any responsibility for the accuracy, validity and completeness of any data; b) shall not be liable for any mistakes, omissions or other flaws on such information, for delays and interruptions in their display, as well as for actions taken based on such information. Neither our company nor our information providers shall be liable for the damage caused by the use of the information provided here. The term ‘business partners’ in this case shall not imply any partnership or agency relationships as well as the creation of a joint venture between our company and any other organization.
You hereby confirm that you shall not copy, modify, reformat, download, store, reproduce, process, transfer or distribute any information published here or use such information for commercial purposes without prior written consent.
Traders Union as well as its external information and content providers retain exclusive copyright to the provided information.
Our company shall not be liable for the products and services advertised on our website.
General websites Disclaimer:
Traders Union (tradersunion.com) shall not be liable for the consequences of trading decisions made by the Client and for the possible loss of his capital resulting from the use of this website and information published on it. Forex market, CFD and cryptocurrency trading involves high risks and is not suitable for everyone. Before investing money, you need to adequately assess the level of your expertise and be aware of the risks, particularly in the context of trading with leverage. The information on this website is not intended for distribution or use by any person in any country or jurisdiction, where such distribution or use would be in violation of the local law or regulation. Any payments by Traders Union (TradersUnion.com) to the users of our website shall be legally interpreted solely as an incentive on our part for the activity on the website in the form of a deduction of a part of the advertising income; they shall not be a subject of any claims of our users or our obligations, a subject of disputes, as well as cannot be considered in relation to the services provided to users by brokers, both in fact and in their completeness and volume. The administration of the website shall not be liable for the content of user comments and reviews about the companies and shall not verify whether the authors of the reviews are indeed real clients of a specific company. All reviews, both negative and positive are published on the website without verification of their reliability; only offensive reviews that call for violence or any kind of discrimination and also reviews published from one group of IP addresses are moderated and removed. The authors of the materials shall be fully liable for the accuracy, completeness and impartiality of any information in the articles and reviews, including in the context of their use or mention of any brand names or trademarks. All mentions of the names of companies and their brands in any materials on the website shall be made in the context of communication of socially important information to the people about their activities by independent journalists, who are the authors. All evaluations and indicators on the website express the subjective opinion of the authors of the reviews (articles) and shall not be viewed as accurate statements and be a subject of disputes and claims against Traders Union.
Risk disclosure:
Information on the TradersUnion.com website is for informational purposes only and does not constitute any motive or suggestion to visitors to invest money. Moreover, we hereby warn you that trading on the Forex and CFD markets is always a high risk. According to the statistics, 75-89% of customers lose the funds invested and only 11-25% of traders earn a profit.
That is why you should only invest money you are willing and able to lose, given the high level of risk involved. Tradersunion.com does not offer financial services, including investment or financial advisory services. Traders Union is not a broker and does not receive compensation for trading in the Forex or CFD markets. Our website only provides informational content about brokers and financial markets and helps users choose the most suitable brokerage company based on comprehensive data and objective analysis..